Audit MicroControls Linearity FD Special Diabetes for Ortho Vitros
- Primary DI
- B085K909M50
- Brand
- Audit MicroControls Linearity FD Special Diabetes for Ortho Vitros
- Company
- AALTO SCIENTIFIC
- Model
- K909M-5
- Published
- 2019-02-14
- Public version status
- Update
- Distribution status
- Not in Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
Identifiers And Packaging#
Identifier, Type, Agency table| Identifier | Type | Agency | Package quantity | Status |
|---|
| B085K909M50 | Primary | HIBCC | 0 | |
GMDN Terms#
Term, Definition table| Term | Definition |
|---|
| Insulin IVD, control | A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of insulin in a clinical specimen. |
Regulatory Flags#
- DUNS number
- 077974989
- Device count
- 1
- Premarket exempt
- true
- Kit
- true
- Lot or batch
- true
- Expiration date on label
- true
Other Devices From This Company#
Primary DI, Brand, Model table| Primary DI | Brand | Model | Catalog | Published |
|---|
| B085K907M50 | Audit MicroControls Linearity LQ CRP for Ortho Vitros | K907M-5 | | 2022-08-30 |
| B085K819M50 | Audit MicroControls Linearity FLQ Anemia for Siemens Atellica | K819M-5 | | 2020-05-05 |
| B085K801M50 | Audit MicroControls Linearity LQ Homocysteine Siemens Atellica | K801M-5 | | 2018-03-27 |
| B085K804M50 | Audit MicroControls Linearity FD Cardiac Markers for Siemens Atellica | K804M-5 | | 2018-03-27 |
| B085K834M50 | Audit MicroControls Linearity FD Procalcitonin | K834M-5 | | 2018-06-22 |
| B085K841M50 | Audit MicroControls Linearity FD Procalcitonin for bioMerieux VIDAS | K841M-5 | | 2018-03-27 |
| B085K845M50 | Audit MicroControls Linearity FD D-Dimer for bioMerieux VIDAS | K845M-5 | | 2019-02-14 |
| B085K962M100 | Audit MicroControls Linearity FD Thryoid for Ortho Vitros | K962M-10 | | 2026-05-15 |
| B085K726M50 | Audit MicroControls Linearity LQ ISE | K726M-5 | | 2018-03-27 |
| B085K745M50 | Audit MicroControls Linearity LQ Osmolality | K745M-5 | | 2026-04-30 |
| B085K905M50 | Audit MicroControls Linearity LQ Direct TIBC for Ortho Vitros | K905M-5 | | 2019-01-02 |
| B085K083M80 | Audit MicroControls Control FD Traumatic Brain Injury (TBI) | K083M-8 | | 2026-03-25 |
| B085K924M100 | Audit MicroControls Linearity FD Tumor Markers for Roche Systems | K924M-10 | | 2025-12-18 |
| B085K895M50 | Audit MicroControls Control LQ Galectin-3 | K895M-5 | | 2019-01-02 |
| B085K087M60 | Audit MicroControls Control LQ COVID-19 IgG + IgM Antibodies | K087M-6 | | 2020-11-12 |
| B085K932M50 | Audit MicroControls Linearity FLQ Troponin T for Roche Systems | K932M-5 | | 2020-11-03 |
| B085K908M50 | Audit MicroControls Linearity FLQ Cardiac Markers for Ortho Vitros | K908M-5 | | 2023-06-15 |
| B085K936M50 | Audit MicroControls Linearity FLQ Cardiac Markers for Roche Systems | K936M-5 | | 2023-06-15 |
| B085K919M50 | Audit MicroControls Linearity FLQ General Chemistry Panel 3 for Roche Systems | K919M-5 | | 2023-06-06 |
| B085K701MSUPP0 | Audit MicroControls Linearity FD Bilirubin Supplement | K701M-SUPP | | 2022-07-12 |